Analgesics (Pharmacies) - Zambia

  • Zambia
  • Revenue in the Analgesics market is projected to reach US$3.88m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 9.69%, resulting in a market volume of US$6.16m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.18 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Zambia is witnessing significant growth and development in recent years.

Customer preferences:
Customers in Zambia have shown a growing preference for analgesics purchased from pharmacies. This can be attributed to the convenience and accessibility offered by pharmacies, as well as the trust and credibility associated with these establishments. Customers value the professional advice and guidance provided by pharmacists, which further enhances their preference for purchasing analgesics from pharmacies.

Trends in the market:
One of the key trends in the Analgesics (Pharmacies) market in Zambia is the increasing demand for over-the-counter (OTC) analgesics. This trend can be attributed to the rising awareness among consumers about self-medication and the availability of a wide range of OTC analgesics in pharmacies. The ease of access to these medications without a prescription has contributed to their popularity among consumers. Another trend in the market is the growing demand for natural and herbal analgesics. Consumers are becoming more health-conscious and are seeking alternative options to traditional analgesics. This trend is driven by the perception that natural and herbal remedies have fewer side effects and are considered safer for long-term use. Pharmacies in Zambia have responded to this trend by expanding their product offerings to include a variety of natural and herbal analgesics.

Local special circumstances:
Zambia has a growing middle class population, which has led to increased disposable income and a higher standard of living. This has resulted in a greater willingness among consumers to spend on healthcare products, including analgesics. Additionally, the government of Zambia has implemented policies to improve the healthcare infrastructure and increase access to healthcare services, which has further contributed to the growth of the Analgesics (Pharmacies) market.

Underlying macroeconomic factors:
The stable economic growth in Zambia has played a significant role in the development of the Analgesics (Pharmacies) market. The country has witnessed increased investment in the healthcare sector, leading to the establishment of more pharmacies and the availability of a wider range of analgesics. Furthermore, the growing population and urbanization in Zambia have created a larger customer base for pharmacies, driving the demand for analgesics. In conclusion, the Analgesics (Pharmacies) market in Zambia is experiencing growth and development due to customer preferences for purchasing from pharmacies, the increasing demand for OTC and natural analgesics, local special circumstances such as a growing middle class population, and underlying macroeconomic factors such as stable economic growth and investment in the healthcare sector.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)